XLON
OIG
Market cap247mUSD
Oct 09, Last price
1,350.00GBP
1D
0.00%
1Q
6.09%
Jan 2017
112.60%
Name
Oryx International Growth Fund Ltd
Chart & performance
P/E
193.12
P/S
14.54
EPS
0.07
Div yield, %
—
Shrs. gr., 5y
-0.16%
Rev. gr., 5y
-34.52%
Revenues
13m
P
Net income
979k
P
CFO
1m
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Oryx International Growth Fund Limited functions as a closed-ended equity investment company, with its operations overseen by Harwood Capital LLP. The fund strategically allocates capital to publicly traded companies within the United Kingdom and United States. Its investment approach emphasizes acquiring stakes in small and mid-capitalization firms, ensuring a broad diversification across various industry sectors. Portfolio creation is guided by rigorous fundamental analysis, and its returns are benchmarked against the FTSE All Share Index. This fund was established on March 2, 1995, and is officially registered in Guernsey, Channel Islands.
Key people
Sidney Cabessa
Non-Executive Director · since 2021
Non-Executive Director · since 1994
Nigel Cayzer
Independent Non-Executive Chairman of the Board · since 1994
Non-Executive Independent Director · since 2022
Gavin Farrell
Non-Executive Independent Director · since 2022
John Grace
Independent Non-Executive Director · since 2011
Non-Executive Independent Director · since 2024
Independent Non-Executive Director · since 2007
IPO date
Mar 03, 1995
Employees
0
Domiciled in
GG
Incorporated in
GG
Legal address
BNP PARIBAS HOUSE
1 ST JULIANS AVENUE
ST PETER PORT GY1 1WA
GG
1 ST JULIANS AVENUE
ST PETER PORT GY1 1WA
GG
Headquarters
6 STRATTON STREET
LONDON, LND W1J 8LD
GB
LONDON, LND W1J 8LD
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||